EX,
When you invest in a company do you invest based on where they've been, or where they're going, or at least on where you believe they're going.
I really can't say what NVCR will do after DCVax-L is approved. No doubt, for those who don't have tumors that can be made into DCVax-L, they'll continue on the helmet. Some may look to do both, NVCR may initiate a trial to use both, then we'll see what the data shows. I have no interest at all in NVCR but gather they're working on more than just brain cancer, so perhaps they'll gain other approvals.
As of now, I wouldn't touch NVCR, but I'd encourage anyone to look at NWBO. I've been in IMGN essentially since it became public, it's been up and down over the years but I believe it's due for major growth. I cannot say the past has been very successful, but I like their future.
I don't know if anyone here bought when they paid the equivalent of $1,200 are still invested, but I bet if they are they've got their average price down to low dollars, or less. NWBO was under a quarter when I first heard of it, I've added at much more than that, but my average is still quite low.
My question to you is, what in your honest opinion is the better investment today?
Gary
News 
Market Data 
Discover 
